Fulcrum Therapeutics Inc

NASDAQ:FULC   4:00:00 PM EDT
7.07
+0.07 (+1.00%)
4:26:20 PM EDT: $7.15 +0.08 (+1.13%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Fulcrum Therapeutics Inc Stock, NASDAQ:FULC

26 Landsdowne Street, Cambridge, Massachusetts 02139
United States of America
Phone: +1.617.651.8851
Number of Employees: 45
http://www.fulcrumtx.com

Description

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.